3.20.2 html 168 259 1 true 45 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.antarespharma.com/20200930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.antarespharma.com/20200930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.antarespharma.com/20200930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.antarespharma.com/20200930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://www.antarespharma.com/20200930/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLossUnaudited Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://www.antarespharma.com/20200930/taxonomy/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquityUnaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.antarespharma.com/20200930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 100070 - Disclosure - Description of Business Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureDescriptionOfBusiness Description of Business Notes 8 false false R9.htm 100080 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Long-Term Debt Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureLongTermDebt Long-Term Debt Notes 10 false false R11.htm 100100 - Disclosure - Share Based Compensation Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureShareBasedCompensation Share Based Compensation Notes 11 false false R12.htm 100110 - Disclosure - Revenues, Significant Customers and Concentrations of Risk Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureRevenuesSignificantCustomersAndConcentrationsOfRisk Revenues, Significant Customers and Concentrations of Risk Notes 12 false false R13.htm 100120 - Disclosure - Earnings per Share Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureEarningsPerShare Earnings per Share Notes 13 false false R14.htm 100130 - Disclosure - Commitments and Contingencies Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100140 - Disclosure - Subsequent Event Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureSubsequentEvent Subsequent Event Notes 15 false false R16.htm 100150 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPolicies 16 false false R17.htm 100160 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesTables Basis of Presentation and Significant Accounting Policies (Tables) Tables http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPolicies 17 false false R18.htm 100170 - Disclosure - Share Based Compensation (Tables) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureShareBasedCompensationTables Share Based Compensation (Tables) Tables http://www.antarespharma.com/20200930/taxonomy/role/DisclosureShareBasedCompensation 18 false false R19.htm 100180 - Disclosure - Revenues, Significant Customers and Concentrations of Risk (Tables) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureRevenuesSignificantCustomersAndConcentrationsOfRiskTables Revenues, Significant Customers and Concentrations of Risk (Tables) Tables http://www.antarespharma.com/20200930/taxonomy/role/DisclosureRevenuesSignificantCustomersAndConcentrationsOfRisk 19 false false R20.htm 100190 - Disclosure - Earnings per Share (Tables) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureEarningsPerShareTables Earnings per Share (Tables) Tables http://www.antarespharma.com/20200930/taxonomy/role/DisclosureEarningsPerShare 20 false false R21.htm 100200 - Disclosure - Description of Business - Additional Information (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetail Description of Business - Additional Information (Detail) Details 21 false false R22.htm 100210 - Disclosure - Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesAdditionalInformationDetail Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) Details 22 false false R23.htm 100220 - Disclosure - Basis of Presentation and Significant Accounting Policies - Inventories (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesInventoriesDetail Basis of Presentation and Significant Accounting Policies - Inventories (Detail) Details http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesTables 23 false false R24.htm 100230 - Disclosure - Basis of Presentation and Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureBasisOfPresentationAndSignificantAccountingPoliciesSummaryOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails Basis of Presentation and Significant Accounting Policies - Summary of Estimated Useful Lives of Property and Equipment (Details) Details 24 false false R25.htm 100240 - Disclosure - Long-Term Debt - Additional Information (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail Long-Term Debt - Additional Information (Detail) Details 25 false false R26.htm 100250 - Disclosure - Share Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureShareBasedCompensationSummaryOfStockOptionActivityDetail Share Based Compensation - Summary of Stock Option Activity (Detail) Details 26 false false R27.htm 100260 - Disclosure - Share Based Compensation - Summary of PSU and RSU Award Activity Under Plan (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureShareBasedCompensationSummaryOfPSUAndRSUAwardActivityUnderPlanDetail Share Based Compensation - Summary of PSU and RSU Award Activity Under Plan (Detail) Details 27 false false R28.htm 100270 - Disclosure - Share Based Compensation - Additional Information (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureShareBasedCompensationAdditionalInformationDetail Share Based Compensation - Additional Information (Detail) Details 28 false false R29.htm 100280 - Disclosure - Share Based Compensation - Summary of Share Based Compensation Allocation Expense (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureShareBasedCompensationSummaryOfShareBasedCompensationAllocationExpenseDetail Share Based Compensation - Summary of Share Based Compensation Allocation Expense (Detail) Details 29 false false R30.htm 100290 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Revenue Disaggregated by Types of Goods and Services and Major Product (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureRevenuesSignificantCustomersAndConcentrationsOfRiskSummaryOfRevenueDisaggregatedByTypesOfGoodsAndServicesAndMajorProductDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Revenue Disaggregated by Types of Goods and Services and Major Product (Detail) Details 30 false false R31.htm 100300 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Revenues Disaggregated by Customer Location (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureRevenuesSignificantCustomersAndConcentrationsOfRiskSummaryOfRevenuesDisaggregatedByCustomerLocationDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Revenues Disaggregated by Customer Location (Detail) Details 31 false false R32.htm 100310 - Disclosure - Revenues, Significant Customers and Concentrations of Risk - Summary of Significant Customers from which the Company Derived 10% or More of Total Revenue (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureRevenuesSignificantCustomersAndConcentrationsOfRiskSummaryOfSignificantCustomersFromWhichCompanyDerived10OrMoreOfTotalRevenueDetail Revenues, Significant Customers and Concentrations of Risk - Summary of Significant Customers from which the Company Derived 10% or More of Total Revenue (Detail) Details 32 false false R33.htm 100320 - Disclosure - Earnings per Share - Summary of Computation for Basic and Diluted Net Earnings (Loss) per Share (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureEarningsPerShareSummaryOfComputationForBasicAndDilutedNetEarningsLossPerShareDetail Earnings per Share - Summary of Computation for Basic and Diluted Net Earnings (Loss) per Share (Detail) Details 33 false false R34.htm 100330 - Disclosure - Subsequent Event - Additional Information (Detail) Sheet http://www.antarespharma.com/20200930/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail Subsequent Event - Additional Information (Detail) Details 34 false false All Reports Book All Reports atrs-10q_20200930.htm atrs-20200930.xsd atrs-20200930_cal.xml atrs-20200930_def.xml atrs-20200930_lab.xml atrs-20200930_pre.xml atrs-ex311_8.htm atrs-ex312_9.htm atrs-ex321_7.htm atrs-ex322_6.htm http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true